Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
Go back to Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study| Bank of Commerce (NASDAQ: ONC) | Delayed: 377.63 -4.64 (1.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $382.27 | 52 Week High | $0.35 | |||
| Open | $384.40 | 52 Week Low | $0.35 | |||
| Day High | $384.40 | P/E | N/A | |||
| Day Low | $372.65 | EPS | $0.00 | |||
| Volume | 315,805 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $1.37 | |||
| Open | $0.51 | 52 Week Low | $0.24 | |||
| Day High | $0.51 | P/E | N/A | |||
| Day Low | $0.49 | EPS | $0.00 | |||
| Volume | 376,008 | |||||



